$CARA Cara Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Cara Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Cara Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Cara Therapeutics, Inc. for free.
CIK Number: 0001346830
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CARA
Company Address: 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD 06902
Phone number: 203-567-1500
Former name: Cara Therapeutics Inc, date of change: 2005-12-13
Market Capitalization: $449.33M
Prev close: $16.30
Average Daily Volume: 1,545,140
Days Low: $16.05
Year Low: $4.26
Year High: $17.20
Cara Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2021 | CARA | Cara Therapeutics, ... | Ives Jeffrey L. | Director | Option Exercise | A | 13.06 | 10,800 | 141,048 | 10,800 | |
Jun 07 2021 | CARA | Cara Therapeutics, ... | Ives Jeffrey L. | Director | Sell | S | 13.05 | 2,520 | 32,886 | 15,380 | 17.9 K to 15.4 K (-14.08 %) |
Jun 07 2021 | CARA | Cara Therapeutics, ... | Ives Jeffrey L. | Director | Grant | A | 0.00 | 7,200 | 0 | 17,900 | 10.7 K to 17.9 K (+67.29 %) |
Jun 07 2021 | CARA | Cara Therapeutics, ... | Shiff Susan Ph.D. | Director | Option Exercise | A | 13.06 | 10,800 | 141,048 | 10,800 | |
Jun 07 2021 | CARA | Cara Therapeutics, ... | Shiff Susan Ph.D. | Director | Option Exercise | A | 13.06 | 10,800 | 141,048 | 10,800 | |
Jun 07 2021 | CARA | Cara Therapeutics, ... | Shiff Susan Ph.D. | Director | Grant | A | 0.00 | 7,200 | 0 | 7,200 | 0 to 7.2 K |
Jun 07 2021 | CARA | Cara Therapeutics, ... | Shiff Susan Ph.D. | Director | Grant | A | 0.00 | 7,200 | 0 | 7,200 | 0 to 7.2 K |
Apr 23 2021 | CARA | Cara Therapeutics, ... | Goncalves Joana | Chief Medical Offic ... | Sell | S | 27.63 | 3,000 | 82,890 | 43,610 | 46.6 K to 43.6 K (-6.44 %) |
Apr 01 2021 | CARA | Cara Therapeutics, ... | Terrillion Scott | Sec'y; Chief Compli ... | Option Exercise | A | 20.59 | 32,000 | 658,880 | 32,000 | |
Apr 01 2021 | CARA | Cara Therapeutics, ... | Terrillion Scott | Sec'y; Chief Compli ... | Grant | A | 0.00 | 16,000 | 0 | 67,342 | 51.3 K to 67.3 K (+31.16 %) |
Apr 01 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Option Exercise | A | 20.59 | 32,000 | 658,880 | 32,000 | |
Apr 01 2021 | CARA | Cara Therapeutics, ... | Menzaghi Frederique Ph.D. | Chief Scientific Of ... | Grant | A | 0.00 | 16,000 | 0 | 135,319 | 119.3 K to 135.3 K (+13.41 %) |
Apr 01 2021 | CARA | Cara Therapeutics, ... | Goncalves Joana | Chief Medical Offic ... | Option Exercise | A | 20.59 | 32,000 | 658,880 | 32,000 | |
Apr 01 2021 | CARA | Cara Therapeutics, ... | Goncalves Joana | Chief Medical Offic ... | Grant | A | 0.00 | 16,000 | 0 | 46,610 | 30.6 K to 46.6 K (+52.27 %) |
Apr 01 2021 | CARA | Cara Therapeutics, ... | CHALMERS DEREK T | President & CEO | Option Exercise | A | 20.59 | 103,000 | 2,120,770 | 103,000 |